Federation Des Caisses Desjardins Du Quebec Biotechnology

Federation Des Caisses Desjardins Du Quebec

$21.3 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TNYA Tenaya Therapeutics, Inc.	$63.3M	$4,000 0.0% of portfolio	8,000	Q2 2025 Added 66.67%
ARCT Arcturus Therapeutics Holdings Inc.	$499M	$3,000 0.0% of portfolio	235	Q1 2025 Reduced 4.08%
BEAM Beam Therapeutics Inc.	$1.71B	$3,000 0.0% of portfolio	200	Q2 2025 Reduced 80.0%
IOVA Iovance Biotherapeutics, Inc.	$342M	$3,000 0.0% of portfolio	2,250	Q4 2024 Added 36.36%
SILO Silo Pharma, Inc.	$2.17M	$3,000 0.0% of portfolio	6,000	Q3 2024 New
PCVX Vaxcyte, Inc.	$2.14B	$3,000 0.0% of portfolio	106	Q1 2025 Added 89.29%
HALO Halozyme Therapeutics, Inc.	$10.2B	$3,000 0.0% of portfolio	75	Q1 2025 New
IMNM Immunome Inc.	$141M	$3,000 0.0% of portfolio	352	Q2 2025 Added 149.65%
ABUS Arbutus Biopharma Corp	$669M	$2,000 0.0% of portfolio	800	Q2 2017 Reduced 20.0%
CADL Candel Therapeutics, Inc.	$149M	$2,000 0.0% of portfolio	500	Q2 2025 Reduced 83.33%
LTRN Lantern Pharma Inc.	$47.4M	$2,000 0.0% of portfolio	800	Q2 2025 New
XLO Xilio Therapeutics, Inc.	$23.4M	$2,000 0.0% of portfolio	3,300	Q4 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$72.1M	$1,000 0.0% of portfolio	1,500	Q3 2024 New
BGNE Bei Gene, Ltd.	$23.5B	$1,000 0.0% of portfolio	5	Q3 2024 New
CRBU Caribou Biosciences, Inc.	$140M	$1,000 0.0% of portfolio	900	Q3 2023 Reduced 44.44%
HRMY Harmony Biosciences Holdings, Inc.	$1.63B	$1,000 0.0% of portfolio	49	Q3 2024 New
RPTX Repare Therapeutics Inc.	$73M	$1,000 0.0% of portfolio	859	Q1 2025 Reduced 22.54%
ANIX Anixa Biosciences Inc	$101M	$1,000 0.0% of portfolio	600	Q1 2025 New
AKBA Akebia Therapeutics, Inc.	$496M	$0 0.0% of portfolio	150	Q1 2018 Sold Out
ALEC Alector, Inc.	$252M	$0 0.0% of portfolio	415	Q3 2024 Reduced 8.79%
APLT Applied Therapeutics Inc.	$28.8M	$0 0.0% of portfolio	84	Q1 2024 New
ARDX Ardelyx, Inc.	$854M	$0 0.0% of portfolio	250	Q3 2024 New
BDTX Black Diamond Therapeutics, Inc.	$134M	$0 0.0% of portfolio	280	Q1 2024 New
CABA Cabaletta Bio, Inc.	$67.6M	$0 0.0% of portfolio	340	Q1 2024 New
DYN Dyne Therapeutics, Inc.	$640M	$0 0.0% of portfolio	20	Q3 2024 New
FATE Fate Therapeutics Inc	$122M	$0 0.0% of portfolio	95	Q4 2021 Reduced 33.68%
GOSS Gossamer Bio, Inc.	$265M	$0 0.0% of portfolio	750	Q3 2024 Reduced 5.06%
GLSI Greenwich Life Sciences, Inc.	$125M	$0 0.0% of portfolio	100	Q3 2024 New
INMB Inmune Bio, Inc.	$37.5M	$0 0.0% of portfolio	400	Q1 2021 Reduced 50.0%
NKTX Nkarta, Inc.	$101M	$0 0.0% of portfolio	100	Q2 2024 New
OMER Omeros Corp	$262M	$0 0.0% of portfolio	300	Q3 2018 Reduced 37.33%
PLX Protalix Bio Therapeutics, Inc.	$111M	$0 0.0% of portfolio	250	Q4 2019 Added 340.0%
QSI Quantum Si Inc	$166M	$0 0.0% of portfolio	50	Q1 2025 Reduced 99.19%
SRPT Sarepta Therapeutics, Inc.	$1.69B	$0 0.0% of portfolio	50	Q3 2024 New
VERA Vera Therapeutics, Inc.	$783M	$0 0.0% of portfolio	20	Q3 2024 New
VIR Vir Biotechnology, Inc.	$757M	$0 0.0% of portfolio	100	Q3 2024 Reduced 60.0%
ALLO Allogene Therapeutics, Inc.	$178M	$0 0.0% of portfolio	100	Q1 2025 New
LEXX Lexaria Bioscience Corp.	$5.65M	$0 0.0% of portfolio	382	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.